These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 2881849

  • 1. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
    Miyachi Y, Yoshioka A, Imamura S, Niwa Y.
    Gut; 1987 Feb; 28(2):190-5. PubMed ID: 2881849
    [Abstract] [Full Text] [Related]

  • 2. Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation.
    Gionchetti P, Guarnieri C, Campieri M, Belluzzi A, Brignola C, Iannone P, Miglioli M, Barbara L.
    Dig Dis Sci; 1991 Feb; 36(2):174-8. PubMed ID: 1671010
    [Abstract] [Full Text] [Related]

  • 3. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kawasaki M, Matsuda A, Kataoka M, Kokurba Y.
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [Abstract] [Full Text] [Related]

  • 4. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kumamoto T, Matsuda A, Kataoka M, Kokuba Y.
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [Abstract] [Full Text] [Related]

  • 5. Anti-oxidant effects of gold compounds.
    Miyachi Y, Yoshioka A, Imamura S, Niwa Y.
    Br J Dermatol; 1987 Jan; 116(1):39-46. PubMed ID: 3028464
    [Abstract] [Full Text] [Related]

  • 6. Anti-oxidant effects of retinoids on inflammatory skin diseases.
    Yoshioka A, Miyachi Y, Imamura S, Niwa Y.
    Arch Dermatol Res; 1986 Jan; 278(3):177-83. PubMed ID: 3015048
    [Abstract] [Full Text] [Related]

  • 7. Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.
    Suematsu M, Suzuki M, Miura S, Nagata H, Oshio C, Asakura H, Watanabe M, Tsuchiya M.
    J Clin Lab Immunol; 1987 May; 23(1):31-3. PubMed ID: 2886669
    [Abstract] [Full Text] [Related]

  • 8. Effect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils.
    Williams JG, Hallett MB.
    Gut; 1989 Nov; 30(11):1581-7. PubMed ID: 2574700
    [Abstract] [Full Text] [Related]

  • 9. Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
    Craven PA, Pfanstiel J, Saito R, DeRubertis FR.
    Gastroenterology; 1987 Jun; 92(6):1998-2008. PubMed ID: 2883067
    [Abstract] [Full Text] [Related]

  • 10. Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ).
    Gionchetti P, Guarnieri C, Campieri M, Belluzzi A, Brignola C, Iannone P, Miglioli M, Barbara L.
    Gut; 1990 Jun; 31(6):730-1. PubMed ID: 1974235
    [No Abstract] [Full Text] [Related]

  • 11. Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes.
    Nielsen OH, Bouchelouche PN, Berild D, Ahnfelt-Rønne I.
    Scand J Gastroenterol; 1993 Jun; 28(6):527-32. PubMed ID: 8100641
    [Abstract] [Full Text] [Related]

  • 12. [The effect of sulphasalazine, sulphapyridine, 5-aminosalicylic acid and prednisolone on superoxide production by human polymorphonuclear leukocytes: in vitro studies].
    Ide T.
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2090. PubMed ID: 3025481
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM, Bartholomew TC, Jewell DP.
    Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649
    [Abstract] [Full Text] [Related]

  • 14. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA.
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.
    Neal TM, Winterbourn CC, Vissers MC.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2765-8. PubMed ID: 2888463
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of roxithromycin on the generation of reactive oxygen species in vitro.
    Akamatsu H, Nishijima S, Akamatsu M, Kurokawa I, Sasaki H, Asada Y.
    J Int Med Res; 1996 Sep 01; 24(1):27-32. PubMed ID: 8674797
    [Abstract] [Full Text] [Related]

  • 19. Effects of sulphasalazine and its metabolites on neutrophil chemotaxis, superoxide production, degranulation and translocation of cytochrome b-245.
    Wandall JH.
    Aliment Pharmacol Ther; 1991 Dec 01; 5(6):609-19. PubMed ID: 1685923
    [Abstract] [Full Text] [Related]

  • 20. Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes--clues to its clinical action?
    Sheldon P, Webb C, Grindulis KA.
    Br J Rheumatol; 1988 Oct 01; 27(5):344-9. PubMed ID: 2902897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.